What is CardiOmegia™?
CardiOmegia™ is extracted from the fruit of an ancient plant grown in Tibetan Plateau called sea buckthorn. With our advanced supercritical CO₂ extraction and purification technology, we are capable of extracting 45% Omega 7 in the natural triglyceride (TG) form.
What is Omega 7?
Omega 7 is a novel unsaturated fatty acid that was first discovered by scientists at Harvard Medical School in 2008.
Researches have shown that Omega 7 is effective in preventing cardiovascular disease and plays a key role in metabolic syndrome, which helps in:
Maintaining normal blood pressure*
Reducing insulin resistance*
Fighting chronic inflammation*
Suppressing appetite to aid weight management*
Lowering LDL*
Increasing HDL*
Reducing blood sugar and serum triglyceride*
Mechanism of Action
Omega 7 Effects on C-Reactive Protein and Serum Lipids
Design: 30-day parallel, double-blinded, randomized, placebo-controlled study with 60 healthy participants.
Dosage: 220.5 mg of Omega 7 per day for 1 month.
Result:
Significant reduction in:
C-Reactive Protein (CRP) by 44%,
Triglyceride (TG) by 15%,
Low-Density Lipoprotein (LDL) by 8%
Significant increase in High-Density Lipoprotein (HDL) by 5%
(Bernstein, Roizen and Martinez, 2014)
Omega 7 Comparison
With our advanced supercritical CO₂ extraction and purification technology, CardiOmegia™ offers up to 45% Omega 7 in its natural triglyceride form, which is up to 4.5X higher when compared with other Omega 7 source.
With just 1 x 500mg CardiOmegia™ softgel per day,
it can meet with the dosage used in a clinical trial.
Specification
CardiOmegia™ Powder
Omega 7 ≥ 15%
Extracted with Supercritical CO₂ Extraction
Micro-encapsulated with TRICAP™ Technology
Certified with the followings:
Recommended Daily Intake: 0.5g per day
Shelf-Life: 3 years
Recommended Daily Intake: 1.5g per day
Shelf-Life: 3 years
Related Article
Technical Document
Product Brochure
Specification - CardiOmegia
Specification - CardiOmegia Powder
Regulatory Info. - CardiOmegia
Regulatory Info. - CardiOmegia Powder
Reference
Bernstein, A., Roizen, M. and Martinez, L. (2014). Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled study. Journal of Clinical Lipidology, [online] 8(6), pp.612-617. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25499944.